Registered Nurse (RN) Respiratory Practice Exam

Albuterol is categorized as a short-acting bronchodilator. This classification is based on its mechanism of action and duration of effects. Albuterol works by stimulating beta-2 adrenergic receptors in the airways, leading to bronchodilation, which helps to improve airflow and relieve symptoms of bronchospasm, such as wheezing and shortness of breath. Its effects generally last for about 4 to 6 hours, which distinguishes it from long-acting bronchodilators that provide extended relief for up to 12 hours or more.

The correct categorization of Albuterol as a short-acting bronchodilator highlights its role as a rescue medication, commonly used in acute situations such as asthma attacks or COPD exacerbations. This reinforces its importance in respiratory therapy as part of a treatment plan for patients needing quick relief from respiratory distress.

In contrast, long-acting bronchodilators are used for maintenance therapy and provide prolonged relief, corticosteroids are anti-inflammatory medications, and combination inhalers typically contain both a bronchodilator and a corticosteroid for comprehensive management of respiratory conditions.